These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease. Yamada H, Ohashi K, Suzuki K, Munetsuna E, Ando Y, Yamazaki M, Ishikawa H, Ichino N, Teradaira R, Hashimoto S. Clin Chim Acta; 2015 Jun 15; 446():267-71. PubMed ID: 25958847 [Abstract] [Full Text] [Related]
7. Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma. Akuta N, Kawamura Y, Suzuki F, Saitoh S, Arase Y, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Suzuki Y, Kobayashi M, Ikeda K, Kumada H. BMC Gastroenterol; 2016 Dec 12; 16(1):141. PubMed ID: 27955628 [Abstract] [Full Text] [Related]
8. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Akuta N, Kawamura Y, Suzuki F, Saitoh S, Arase Y, Kunimoto H, Sorin Y, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Suzuki Y, Kobayashi M, Ikeda K, Kumada H. Hepatol Int; 2016 Jul 12; 10(4):647-56. PubMed ID: 27074850 [Abstract] [Full Text] [Related]
9. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, Kronenberger B, Piiper A. J Viral Hepat; 2012 Feb 12; 19(2):e58-65. PubMed ID: 22239527 [Abstract] [Full Text] [Related]
10. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance. Johnson K, Leary PJ, Govaere O, Barter MJ, Charlton SH, Cockell SJ, Tiniakos D, Zatorska M, Bedossa P, Brosnan MJ, Cobbold JF, Ekstedt M, Aithal GP, Clément K, Schattenberg JM, Boursier J, Ratziu V, Bugianesi E, Anstee QM, Daly AK, LITMUS Consortium Investigators§, LITMUS Consortium Investigators. JHEP Rep; 2022 Feb 12; 4(2):100409. PubMed ID: 35072021 [Abstract] [Full Text] [Related]
17. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease. Salvoza NC, Klinzing DC, Gopez-Cervantes J, Baclig MO. PLoS One; 2016 Sep 12; 11(4):e0153497. PubMed ID: 27077736 [Abstract] [Full Text] [Related]
18. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Ao R, Wang Y, Tong J, Wang BF. Med Sci Monit; 2016 Oct 19; 22():3804-3819. PubMed ID: 27756894 [Abstract] [Full Text] [Related]